Jenoptik tightens precautions ahead of 2025 - Jenoptik tightens its safety measures for the year 2025
Jenoptik, a leading technology conglomerate based in Jena, Germany, has issued a cautious outlook for 2025 due to uncertainties from US trade policies and resulting tariffs. The company now anticipates that its full-year revenue for 2025 will decline compared to 2024's €1.12 billion, contrary to earlier more optimistic forecasts.
The impact of US tariffs has reduced direct customer demand and caused wider economic uncertainty, especially affecting Jenoptik’s semiconductor equipment and automotive-related businesses in North America. This uncertain tariff environment has also influenced the decision to shelve the planned sale of its Prodomax automotive unit, as investment restraint in the North American automotive sector remains high.
Despite these challenges, Jenoptik noted some positive signs in the semiconductor equipment, life science, and medical technology segments, with order intake improving in the second quarter of 2025 compared to a weak first quarter. However, the company has intensified cost management efforts to counterbalance the negative effects of tariffs and trade barriers.
In financial terms, Jenoptik expects its EBITDA margin to fall into the lower half of its forecast range of 18 to 21%. This reflects the cautious revenue outlook and ongoing cost pressures caused by trade uncertainties.
In the first six months of 2025, Jenoptik's revenue decreased by nearly eight percent to around €498 million. This decline in revenue is expected to continue into the full year, with the company now forecasting revenues to be at the lower end of the previously forecast range. If achieved, this would mean that Jenoptik's revenue for 2025 would be the same as the previous year, with a decline and an increase of 5 percent.
In summary, Jenoptik’s 2025 revenue outlook is expected to be at the lower end of the previously forecast range, primarily due to uncertainties from US trade policies and resulting tariffs. The company now anticipates that its full-year revenue for 2025 will decline compared to 2024’s €1.12 billion, contrary to earlier more optimistic forecasts. It expects revenue to be in the lower half of its previous guidance range, which allowed for a ±5% variation around 2024 levels, effectively signaling a likely revenue decrease. The company has intensified cost management efforts to counterbalance the negative effects of tariffs and trade barriers, while maintaining a focus on positive developments in the semiconductor, life science, and medical technology segments.
- In light of the company's cautious outlook, Jenoptik is considering improving its community policy to reduce costs, potentially including vocational training programs for employees to increase efficiency and productivity.
- To adapt to the current economic climate, Jenoptik is exploring innovative technology solutions for its business operations, aiming to optimize finance management and maintain a competitive edge in the market.
